Transition Elle
Natural health product licensed in Canada
- Licence holder
- Vitaminol Inc.
- NPN or DIN-HM
- 80028595
- Status
- Active licence
- Licence date
- 12 December 2011
- Revision date
- Not provided
- Form
- Kit
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Medicago sativa Source : Feuille | 100 mg | Not calculated |
| Valeriana officinalis Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Equisetum arvense Source : Parties aériennes | 100 mg | Not calculated |
| Oenothera biennis Source : Graine(s) | 300 mg | Not calculated |
| Salvia officinalis Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Gadus morhua Source : Foie | 17.5 mg | Not calculated |
| Actaea racemosa Source : Racine | 300 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Oryza sativa, Hypromellose, Dioxyde de silicium, Hydroxypropylcellulose, chlorophylline de cuivre sodium, Dioxyde de titane, Poly(éthylène glycol), prêle, Dioxyde de silicium colloïdal, Cire de Carnauba, Eau purifiée, Calcium phosphate dibasic, Huile de fève de soja, Calcium phosphate, Cire d'abeille jaune, Stéarate de magnésium, Lécithine, Glycérine, Huile de foie de morue, Croscarmellose de sodium, Vitamine E, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 sachet | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Bio F Source of essential fatty acids for the maintenance of good health. Flavonelle and Osma Plus are sources of calcium that as part of a healthy diet may help prevent bone loss and osteoporosis. Sauge Fémina and Black cohosh 540mg help reduce menopausal symptoms, such as hot flashes, night sweating, mood and sleep disturbance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80028595
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.